Quantcast

Latest cancer therapy Stories

2010-06-24 07:30:00

NEW YORK, June 24 /PRNewswire/ -- Can the foods we eat actually help us battle and emerge victorious over cancer and other life-threatening diseases? For over 40 years, hundreds of patients from around the globe have foregone toxic chemicals and radiation to follow the course called "bio-repair," which uses organic nutrition, detoxification and other techniques to bring the body to a state where it can literally heal itself from cancer and other diseases.

2010-06-17 19:00:00

PITTSBURGH, June 17 /PRNewswire/ -- Bain Capital Ventures, the venture and growth affiliate of Bain Capital, recently led a financing of $35 million in Precision Therapeutics.

2010-05-26 06:30:00

CALGARY, May 26 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S.

2010-03-30 06:30:00

CALGARY, March 30 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S.

2009-11-03 09:04:00

WALTHAM, Mass, Nov. 3 /PRNewswire/ -- On-Q-ity, a next-generation oncology diagnostics company focused on improving cancer therapy effectiveness, announced today that it has closed a $21 million series A financing.

2009-10-16 16:31:00

BRIDGEWATER, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced that the U.S.

2009-09-24 06:30:00

CALGARY, Sept. 24 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S.

2009-07-30 07:00:00

WILMINGTON, Del., July 30 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the company has submitted a New Drug Application to the U.S.

2009-06-18 14:53:29

Chemists at the University of California-Santa Cruz say they've developed novel compounds that show promise for photodynamic cancer therapy. The compounds, called dye-sensitized ruthenium nitrosyls, are absorbed by cancer cells and respond to specific wavelengths of light by releasing nitric oxide, which triggers the cancer cells' death, the researchers said. For cancer treatment, you want localized delivery of a very high concentration of nitric oxide, said Professor Pradip Mascharak.


Word of the Day
chomage
  • Stoppage; cessation (of labor).
  • A standing still or idling (of mills, factories, etc.).
The word chomage comes into English from French.]
Related